Q2 2025 Holdings
Filed 2025-08-14 | 5 holdings | $43.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Entrada Therapeutics, Inc.(TRDA) | Common | 29384C108 | $29.4M | 4,381,062 | 67.9% |
| Dyne Therapeutics, Inc.(DYN) | Common | 26818M108 | $6.5M | 682,376 | 15.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $4.7M | 4,309,860 | 10.8% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $1.6M | 1,121,318 | 3.6% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADS | 00653A107 | $1.2M | 4,809,677 | 2.7% |